![](/img/cover-not-exists.png)
Cerebel (EGF111438): An Open Label Randomized Phase III Study Comparing the Incidence of CNS Metastases in Patients (PTS) with HER2+ Metastatic Breast Cancer (MBC), Treated with Lapatinib Plus Capecitabine (LC) Versus Trastuzumab Plus Capecitabine (TC)
Pivot, X., Semiglazov, V., Żurawski, B., Allerton, R., Fabi, A., Ciruelos, E., Parikh, R., DeSilvio, M., Santillana, S., Swaby, R.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34361-1
Date:
September, 2012
File:
PDF, 58 KB
2012